Clinical Trials in Maryland

Showing 2301-2320 of 11,119 trials

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

NCT04629508

This is a 2-part study. In Part 1, participants will be dosed at 2 different dose levels in order to select the RP2D for Part 2 of the study.

MyelofibrosisPolycythemia VeraThrombocythemia

Incyte Corporation4 participantsStarted Jul 2021

New Orleans, Louisiana, United States • Bethesda, Maryland, United States • Kansas City, Missouri, United States +18 more locations

SUSPENDEDNA17 miles

Physician-modified Endovascular Graft for Repair of Complex Thoracoabdominal and Abdominal Aortic Aneurysms

NCT04526938

The primary objective of this study is to assess the use of a physician-modified Cook Alpha Thoracic Endovascular Graft in the repair of complex aortic aneurysms and thoracoabdominal aortic aneurysms and aneurysms secondary to aortic dissections in high-risk patients having appropriate anatomy. The primary intent of the study is to assess the safety and preliminary effectiveness of the device. Additionally, the study will assess renal function, radiation exposure, and quality of life.

Juxtarenal Aortic AneurysmSuprarenal Aortic AneurysmThoracoabdominal Aortic Aneurysm

Medstar Health Research Institute200 participantsStarted Sep 2021

Washington D.C., District of Columbia, United States

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

Physician-modified Endovascular Graft for Repair of Complex Thoracoabdominal and Abdominal Aortic Aneurysms

Find Trials by Condition in Maryland

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

MR Image Synthesis With Low Gadobutrol Dose and AI

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001

A Study of LY3549492 in Healthy Weight Adult Participants